A. Lienhart, Y. Auroy, F. Péquignot, D. Benhamou, J. Warszawski et al., Survey of Anesthesia-related Mortality in France, Anesthesiology, vol.105, issue.6, pp.1087-97, 2006.
DOI : 10.1097/00000542-200612000-00008

C. Murry, R. Jennings, and K. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, vol.74, issue.5, pp.1124-1160, 1986.
DOI : 10.1161/01.CIR.74.5.1124

J. Bland and E. Lowenstein, Halothane-induced Decrease in Experimental Myocardial Ischemia in the Non-failing Canine Heart, Anesthesiology, vol.45, issue.3, pp.287-93, 1976.
DOI : 10.1097/00000542-197609000-00006

D. Warltier, M. Wathiqui, J. Kampine, and W. Schmeling, Recovery of Contractile Function of Stunned Myocardium in Chronically Instrumented Dogs is Enhanced by Halothane or Isoflurane, Anesthesiology, vol.69, issue.4, pp.552-65, 1988.
DOI : 10.1097/00000542-198810000-00016

D. Cope, W. Impastato, M. Cohen, and J. Downey, Volatile Anesthetics Protect the Ischemic Rabbit Myocardium from Infarction, Anesthesiology, vol.86, issue.3, pp.699-709, 1997.
DOI : 10.1097/00000542-199703000-00023

J. Kersten, T. Schmeling, P. Pagel, G. Gross, and D. Warltier, Isoflurane Mimics Ischemic Preconditioning via Activation of KATP Channels, Anesthesiology, vol.87, issue.2, pp.361-70, 1997.
DOI : 10.1097/00000542-199708000-00024

B. Cason, A. Gamperl, R. Slocum, and R. Hickey, Anesthetic-induced Preconditioning, Anesthesiology, vol.87, issue.5, pp.1182-90, 1997.
DOI : 10.1097/00000542-199711000-00023

W. Toller, J. Kersten, P. Pagel, D. Hettrick, and D. Warltier, Sevoflurane Reduces Myocardial Infarct Size and Decreases the Time Threshold for Ischemic Preconditioning in Dogs, Anesthesiology, vol.91, issue.5, pp.1437-1483, 1999.
DOI : 10.1097/00000542-199911000-00037

S. Hert, . De, S. Cromheecke, P. Broecke, . Ten et al., Effects of Propofol, Desflurane, and Sevoflurane on Recovery of Myocardial Function after Coronary Surgery in Elderly High-risk Patients, Anesthesiology, vol.99, issue.2, pp.314-337, 2003.
DOI : 10.1097/00000542-200308000-00013

S. Hert, . De, P. Broecke, . Ten, E. Mertens et al., Sevoflurane but Not Propofol Preserves Myocardial Function in Coronary Surgery Patients, Anesthesiology, vol.97, issue.1, pp.42-51, 2002.
DOI : 10.1097/00000542-200207000-00007

S. Hert, . De, P. Linden, . Van-der, S. Cromheecke et al., Choice of Primary Anesthetic Regimen Can Influence Intensive Care Unit Length of Stay after Coronary Surgery with Cardiopulmonary Bypass, Anesthesiology, vol.101, issue.1, pp.9-20, 2004.
DOI : 10.1097/00000542-200407000-00005

S. Hert, . De, P. Linden, . Van-der, S. Cromheecke et al., Cardioprotective Properties of Sevoflurane in Patients Undergoing Coronary Surgery with Cardiopulmonary Bypass Are Related to the Modalities of Its Administration, Anesthesiology, vol.101, issue.2, pp.299-310, 2004.
DOI : 10.1097/00000542-200408000-00009

P. Conzen, S. Fischer, C. Detter, and K. Peter, Sevoflurane Provides Greater Protection of the Myocardium than Propofol in Patients Undergoing Off-pump Coronary Artery Bypass Surgery, Anesthesiology, vol.99, issue.4, pp.826-859, 2003.
DOI : 10.1097/00000542-200310000-00013

D. Belhomme, J. Peynet, M. Louzy, J. Launay, M. Kitakaze et al., Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery, Circulation, vol.100, issue.Supplement 2, pp.340-344, 1999.
DOI : 10.1161/01.CIR.100.suppl_2.II-340

K. Julier, R. Silva, . Da, C. Garcia, L. Bestmann et al., Preconditioning by Sevoflurane Decreases Biochemical Markers for Myocardial and Renal Dysfunction in Coronary Artery Bypass Graft Surgery: A Double-blinded, Placebo-controlled, Multicenter Study, Anesthesiology, vol.98, issue.6, pp.1315-1342, 2003.
DOI : 10.1097/00000542-200306000-00004

E. Lucchinetti, C. Hofer, L. Bestmann, M. Hersberger, J. Feng et al., Gene Regulatory Control of Myocardial Energy Metabolism Predicts Postoperative Cardiac Function in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery, Anesthesiology, vol.106, issue.3, pp.444-57, 2007.
DOI : 10.1097/00000542-200703000-00008

J. Symons and P. Myles, Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis, British Journal of Anaesthesia, vol.97, issue.2, pp.127-163, 2006.
DOI : 10.1093/bja/ael149

P. Pagel, Myocardial Protection by Volatile Anesthetics in Patients Undergoing Cardiac Surgery: A Critical Review of the Laboratory and Clinical Evidence, Journal of Cardiothoracic and Vascular Anesthesia, vol.27, issue.5, pp.972-82, 2013.
DOI : 10.1053/j.jvca.2012.10.011

L. Kevin, E. Novalija, M. Riess, A. Camara, S. Rhodes et al., Sevoflurane Exposure Generates Superoxide but Leads to Decreased Superoxide During Ischemia and Reperfusion in Isolated Hearts, Anesthesia & Analgesia, vol.96, pp.949-955, 2003.
DOI : 10.1213/01.ANE.0000052515.25465.35

K. Tanaka, D. Weihrauch, F. Kehl, L. Ludwig, J. Ladisa et al., Mechanism of Preconditioning by Isoflurane in Rabbits: A Direct Role for Reactive Oxygen Species, Anesthesiology, vol.97, issue.6, pp.1485-90, 2002.
DOI : 10.1097/00000542-200212000-00021

K. Tanaka, D. Weihrauch, L. Ludwig, J. Kersten, P. Pagel et al., Mitochondrial Adenosine Triphosphate???regulated Potassium Channel Opening Acts as a Trigger for Isoflurane-induced Preconditioning by Generating Reactive Oxygen Species, Anesthesiology, vol.98, issue.4, pp.935-978, 2003.
DOI : 10.1097/00000542-200304000-00021

R. Bouwman, R. Musters, B. Beek-harmsen, . Van, J. Lange et al., Reactive Oxygen Species Precede Protein Kinase C-?? Activation Independent of Adenosine Triphosphate???sensitive Mitochondrial Channel Opening in Sevoflurane-induced Cardioprotection, Anesthesiology, vol.100, issue.3, pp.506-520, 2004.
DOI : 10.1097/00000542-200403000-00008

N. Hirata, Y. Shim, D. Pravdic, N. Lohr, P. Pratt et al., Isoflurane Differentially Modulates Mitochondrial Reactive Oxygen Species Production via Forward versus Reverse Electron Transport Flow, Anesthesiology, vol.115, issue.3, pp.531-571, 2011.
DOI : 10.1097/ALN.0b013e31822a2316

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337729

X. Lu, H. Liu, L. Wang, and S. Schaefer, Activation of NF-??B is a critical element in the antiapoptotic effect of anesthetic preconditioning, AJP: Heart and Circulatory Physiology, vol.296, issue.5, pp.1296-1304, 2009.
DOI : 10.1152/ajpheart.01282.2008

J. Hanouz, L. Zhu, S. Lemoine, C. Durand, O. Lepage et al., Reactive Oxygen Species Mediate Sevoflurane- and Desflurane-Induced Preconditioning in Isolated Human Right Atria In Vitro, Anesthesia & Analgesia, vol.105, issue.6
DOI : 10.1213/01.ane.0000286170.22307.1a

M. Towler and D. Hardie, AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling, Circulation Research, vol.100, issue.3, pp.328-369, 2007.
DOI : 10.1161/01.RES.0000256090.42690.05

C. Collard and S. Gelman, Pathophysiology, Clinical Manifestations, and Prevention of Ischemia-Reperfusion Injury, Anesthesiology, vol.94, issue.6, pp.1133-1141, 2001.
DOI : 10.1097/00000542-200106000-00030

M. Avkiran and M. Marber, Na+/h+exchange inhibitors for cardioprotective therapy: progress, problems and prospects, Journal of the American College of Cardiology, vol.39, issue.5, pp.747-53, 2002.
DOI : 10.1016/S0735-1097(02)01693-5

H. Liu, H. Zhang, X. Zhu, Z. Shao, and Z. Yao, channels and PKC-??, American Journal of Physiology - Heart and Circulatory Physiology, vol.282, issue.4, pp.1380-1386, 2002.
DOI : 10.1152/ajpheart.00348.2001

D. Yellon and D. Hausenloy, Myocardial Reperfusion Injury, New England Journal of Medicine, vol.357, issue.11, pp.1121-1156, 2007.
DOI : 10.1056/NEJMra071667

D. Hausenloy and D. Yellon, Myocardial ischemia-reperfusion injury: a neglected therapeutic target, Journal of Clinical Investigation, vol.123, issue.1, pp.92-100, 2013.
DOI : 10.1172/JCI62874

Z. Zhao and J. Vinten-johansen, Myocardial apoptosis and ischemic preconditioning, Cardiovascular Research, vol.55, issue.3, pp.438-55, 2002.
DOI : 10.1016/S0008-6363(02)00442-X

URL : http://cardiovascres.oxfordjournals.org/cgi/content/short/55/3/438

J. Jordan, Z. Zhao, and J. Vinten-johansen, The role of neutrophils in myocardial ischemia???reperfusion injury, Cardiovascular Research, vol.43, issue.4, pp.860-78, 1999.
DOI : 10.1016/S0008-6363(99)00187-X

J. Vinten-johansen, Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury, Cardiovascular Research, vol.61, issue.3, pp.481-97, 2004.
DOI : 10.1016/j.cardiores.2003.10.011

L. Terada, J. Rubinstein, E. Lesnefsky, L. Horwitz, J. Leff et al., Existence and participation of xanthine oxidase in reperfusion injury of ischemic rabbit myocardium, Am. J. Physiol, vol.260, pp.805-810, 1991.

H. Simon, A. Haj-yehia, and F. Levi-schaffer, Role of reactive oxygen species (ROS) in apoptosis induction, APOPTOSIS, vol.5, issue.5, pp.415-423, 2000.
DOI : 10.1023/A:1009616228304

J. Kerr, A. Wyllie, and A. Currie, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, British Journal of Cancer, vol.26, issue.4, pp.239-57, 1972.
DOI : 10.1038/bjc.1972.33

L. Galluzzi, I. Vitale, J. Abrams, E. Alnemri, E. Baehrecke et al., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, pp.107-127, 2012.
DOI : 10.1083/jcb.200712051

T. Cotter, Apoptosis and cancer: the genesis of a research field, Nature Reviews Cancer, vol.112, issue.7, pp.501-508, 2009.
DOI : 10.1038/nrc2663

C. Johnson and S. Kornbluth, Caspase Cleavage Is Not for Everyone, Cell, vol.134, issue.5, pp.720-721, 2008.
DOI : 10.1016/j.cell.2008.08.019

W. Fiers, R. Beyaert, E. Boone, S. Cornelis, W. Declercq et al., TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis, J. Inflamm, vol.47, pp.67-75, 1995.

H. Shen and P. Codogno, Autophagic cell death: Loch Ness monster or endangered species?, Autophagy, vol.7, issue.5, pp.457-65, 2011.
DOI : 10.4161/auto.7.5.14226

S. Tait and D. Green, Caspase-independent cell death: leaving the set without the final cut, Oncogene, vol.4, issue.50, pp.6452-61, 2008.
DOI : 10.1016/j.ejca.2007.01.029

F. Llambi and D. Green, Apoptosis and oncogenesis: give and take in the BCL-2 family, Current Opinion in Genetics & Development, vol.21, issue.1, pp.12-20, 2011.
DOI : 10.1016/j.gde.2010.12.001

J. Chipuk, T. Moldoveanu, F. Llambi, M. Parsons, and D. Green, The BCL-2 Family Reunion, Molecular Cell, vol.37, issue.3, pp.299-310, 2010.
DOI : 10.1016/j.molcel.2010.01.025

S. Willis, J. Fletcher, T. Kaufmann, M. Delft, . Van et al., Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak, Science, vol.315, issue.5813, pp.856-865, 2007.
DOI : 10.1126/science.1133289

C. Chen, L. Edelstein, and C. Gélinas, The Rel/NF-kappa B Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL, Molecular and Cellular Biology, vol.20, issue.8, pp.2687-95, 2000.
DOI : 10.1128/MCB.20.8.2687-2695.2000

N. Chen, X. Chen, R. Huang, H. Zeng, J. Gong et al., BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1??, Journal of Biological Chemistry, vol.284, issue.15, pp.10004-10016, 2009.
DOI : 10.1074/jbc.M805997200

T. Tang, D. Dowbenko, A. Jackson, L. Toney, D. Lewin et al., The Forkhead Transcription Factor AFX Activates Apoptosis by Induction of the BCL-6 Transcriptional Repressor, Journal of Biological Chemistry, vol.277, issue.16, pp.14255-65, 2002.
DOI : 10.1074/jbc.M110901200

D. Heyland, J. Muscedere, P. Wischmeyer, D. Cook, G. Jones et al., A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients, New England Journal of Medicine, vol.368, issue.16, pp.1489-97, 2013.
DOI : 10.1056/NEJMoa1212722

K. Burns, M. Chu, R. Novick, S. Fox, K. Gallo et al., Perioperative N-acetylcysteine to Prevent Renal Dysfunction in High-Risk Patients Undergoing CABG Surgery, JAMA, vol.294, issue.3, pp.342-50, 2005.
DOI : 10.1001/jama.294.3.342

J. Frässdorf, S. Hert, . De, and W. Schlack, Anaesthesia and myocardial ischaemia/reperfusion injury, British Journal of Anaesthesia, vol.103, issue.1, pp.89-98, 2009.
DOI : 10.1093/bja/aep141

M. Zaugg, E. Lucchinetti, M. Uecker, T. Pasch, and M. Schaub, Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms, British Journal of Anaesthesia, vol.91, issue.4, pp.551-65, 2003.
DOI : 10.1093/bja/aeg205

URL : http://bja.oxfordjournals.org/cgi/content/short/91/4/566

M. Uecker, R. Silva, . Da, T. Grampp, T. Pasch et al., Translocation of Protein Kinase C Isoforms to Subcellular Targets in Ischemic and Anesthetic Preconditioning, Anesthesiology, vol.99, issue.1, pp.138-185, 2003.
DOI : 10.1097/00000542-200307000-00023

W. Toller, E. Gross, J. Kersten, P. Pagel, G. Gross et al., Sarcolemmal and Mitochondrial Adenosine Triphosphate??? dependent Potassium Channels, Anesthesiology, vol.92, issue.6, pp.1731-1740, 2000.
DOI : 10.1097/00000542-200006000-00033

C. Zhong, Y. Zhou, and H. Liu, Nuclear Factor ??B and Anesthetic Preconditioning during Myocardial Ischemia-Reperfusion, Anesthesiology, vol.100, issue.3, pp.540-546, 2004.
DOI : 10.1097/00000542-200403000-00012

J. Raphael, Z. Zuo, S. Abedat, R. Beeri, and Y. Gozal, Isoflurane Preconditioning Decreases Myocardial Infarction in Rabbits via Up-regulation of Hypoxia Inducible Factor 1 That Is Mediated by Mammalian Target of Rapamycin, Anesthesiology, vol.108, issue.3, pp.415-440, 2008.
DOI : 10.1097/ALN.0b013e318164cab1

J. Raphael, J. Rivo, and Y. Gozal, Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling, British Journal of Anaesthesia, vol.95, issue.6, pp.756-63, 2005.
DOI : 10.1093/bja/aei264

R. Silva, . Da, T. Grampp, T. Pasch, M. Schaub et al., Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning, Anesthesiology, vol.100, issue.1, pp.59-69, 2004.
DOI : 10.1097/00000542-200401000-00013

J. Hanouz, A. Yvon, M. Massetti, O. Lepage, G. Babatasi et al., Mechanisms of Desflurane-induced Preconditioning in Isolated Human Right Atria In Vitro, Anesthesiology, vol.97, issue.1, pp.33-41, 2002.
DOI : 10.1097/00000542-200207000-00006

D. Hardie, The AMP-activated protein kinase pathway - new players upstream and downstream, Journal of Cell Science, vol.117, issue.23, pp.5479-87, 2004.
DOI : 10.1242/jcs.01540

M. Mahlapuu, C. Johansson, K. Lindgren, G. Hjälm, B. Barnes et al., Expression profiling of the ??-subunit isoforms of AMP-activated protein kinase suggests a major role for ??3 in white skeletal muscle, AJP: Endocrinology and Metabolism, vol.286, issue.2, pp.194-200, 2004.
DOI : 10.1152/ajpendo.00147.2003

A. Woods, S. Johnstone, K. Dickerson, F. Leiper, L. Fryer et al., LKB1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade, Current Biology, vol.13, issue.22, pp.12004-12012, 2003.
DOI : 10.1016/j.cub.2003.10.031

URL : https://hal.archives-ouvertes.fr/inserm-00390855

S. Hawley, D. Pan, K. Mustard, L. Ross, J. Bain et al., Calmodulin-dependent protein kinase kinase-?? is an alternative upstream kinase for AMP-activated protein kinase, Cell Metabolism, vol.2, issue.1, pp.9-19, 2005.
DOI : 10.1016/j.cmet.2005.05.009

M. Momcilovic, S. Hong, and M. Carlson, Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro, Journal of Biological Chemistry, vol.281, issue.35
DOI : 10.1074/jbc.M604399200

Z. Chen, X. Shen, F. Shen, W. Zhong, H. Wu et al., TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70, Molecular and Cellular Biochemistry, vol.107, issue.Suppl 4, pp.35-44, 2013.
DOI : 10.1007/s11010-013-1568-z

M. Foretz, N. Ancellin, F. Andreelli, Y. Saintillan, P. Grondin et al., Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver, Diabetes, vol.54, issue.5, pp.1331-1340, 2005.
DOI : 10.2337/diabetes.54.5.1331

R. Russell, R. Bergeron, G. Shulman, and L. Young, Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR, Am. J. Physiol, vol.277, pp.643-649, 1999.

A. Marsin, L. Bertrand, M. Rider, J. Deprez, C. Beauloye et al., Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia, Current Biology, vol.10, issue.20, pp.1247-55, 2000.
DOI : 10.1016/S0960-9822(00)00742-9

X. Ma and J. Blenis, Molecular mechanisms of mTOR-mediated translational control, Nature Reviews Molecular Cell Biology, vol.27, issue.5, pp.307-325, 2009.
DOI : 10.1038/nrm2672

D. Bolster, S. Crozier, S. Kimball, and L. Jefferson, AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling, Journal of Biological Chemistry, vol.277, issue.27, pp.23977-80, 2002.
DOI : 10.1074/jbc.C200171200

A. Meijer and P. Codogno, AMP-Activated Protein Kinase and Autophagy, Autophagy, vol.3, issue.3, pp.238-278, 2007.
DOI : 10.4161/auto.3710

URL : https://hal.archives-ouvertes.fr/inserm-00175293

N. Ouslimani, J. Peynet, D. Bonnefont-rousselot, P. Thérond, A. Legrand et al., Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells, Metabolism, vol.54, issue.6, pp.829-863, 2005.
DOI : 10.1016/j.metabol.2005.01.029

J. Hescheler, R. Meyer, S. Plant, D. Krautwurst, W. Rosenthal et al., Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart, Circulation Research, vol.69, issue.6, pp.1476-86, 1991.
DOI : 10.1161/01.RES.69.6.1476

K. Zitta, P. Meybohm, B. Bein, H. Ohnesorge, M. Steinfath et al., Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: Findings from a human, in-vitro hypoxia model, European Journal of Pharmacology, vol.645, issue.1-3, pp.39-46, 2010.
DOI : 10.1016/j.ejphar.2010.07.017

W. Claycomb, N. Lanson, . Jr, B. Stallworth, D. Egeland et al., HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte, Proc. Natl. Acad
DOI : 10.1073/pnas.95.6.2979

M. Park, B. Youn, X. Zheng, D. Wu, A. Xu et al., Globular Adiponectin, Acting via AdipoR1/APPL1, Protects H9c2 Cells from Hypoxia/Reoxygenation-Induced Apoptosis, PLoS ONE, vol.119, issue.2, p.19143, 2011.
DOI : 10.1371/journal.pone.0019143.g005

URL : http://doi.org/10.1371/journal.pone.0019143

I. Cuadrado, M. Fernández-velasco, L. Boscá, L. Heras, and B. De, Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation, Cell Death and Disease, vol.553, issue.11, p.229, 2011.
DOI : 10.1038/cddis.2011.113

G. Yogalingam, S. Hwang, J. Ferreira, and D. Mochly-rosen, Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase C?? (PKC??) Inhibits Mitochondria Elimination by Lysosomal-like Structures following Ischemia and Reoxygenation-induced Injury, Journal of Biological Chemistry, vol.288, issue.26, pp.18947-60, 2013.
DOI : 10.1074/jbc.M113.466870

N. Franks and W. Lieb, Temperature Dependence of the Potency of Volatile General Anesthetics, Anesthesiology, vol.84, issue.3, pp.716-736, 1996.
DOI : 10.1097/00000542-199603000-00027

D. Strum and E. Eger, Partition Coefficients for Sevoflurane in Human Blood, Saline, and Olive Oil, Anesthesia & Analgesia, vol.66, issue.7, pp.654-660, 1987.
DOI : 10.1213/00000539-198707000-00013

R. Haseneder, S. Kratzer, L. Meyer, . Von, M. Eder et al., Isoflurane and sevoflurane dose-dependently impair hippocampal long-term potentiation, European Journal of Pharmacology, vol.623, issue.1-3, pp.47-51, 2009.
DOI : 10.1016/j.ejphar.2009.09.022

K. Nishikawa, K. Kubo, J. Ishizeki, T. Takazawa, S. Saito et al., The interaction of noradrenaline with sevoflurane on GABA(A) receptor-mediated inhibitory postsynaptic currents in the rat hippocampus, Brain Research, vol.1039, issue.1-2, pp.153-61, 2005.
DOI : 10.1016/j.brainres.2005.01.060

T. Katoh and K. Ikeda, The Minimum Alveolar Concentration (MAC) of Sevoflurane in Humans, Anesthesiology, vol.66, issue.3, pp.301-304, 1987.
DOI : 10.1097/00000542-198703000-00006

T. Lin, C. Lu, C. Li, C. Chang, and S. Ho, Arterial blood concentration of sevoflurane during single-breath induction and tracheal intubation in gynecologic patients, Journal of Clinical Anesthesia, vol.20, issue.7, pp.496-500, 2008.
DOI : 10.1016/j.jclinane.2008.05.011

R. Lamberts, G. Onderwater, N. Hamdani, M. Vreden, J. Steenhuisen et al., Reactive Oxygen Species-Induced Stimulation of 5'AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection, Circulation, vol.120, issue.11_suppl_1, pp.10-15, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.828426

C. Lotz, B. Fisslthaler, A. Redel, T. Smul, J. Stumpner et al., Activation of Adenosine-Monophosphate???Activated Protein Kinase Abolishes Desflurane-Induced Preconditioning Against Myocardial Infarction In Vivo, Journal of Cardiothoracic and Vascular Anesthesia, vol.25, issue.1, pp.66-71, 2011.
DOI : 10.1053/j.jvca.2010.02.007

J. Raphael, S. Abedat, J. Rivo, K. Meir, R. Beeri et al., Volatile Anesthetic Preconditioning Attenuates Myocardial Apoptosis in Rabbits after Regional Ischemia and Reperfusion via Akt Signaling and Modulation of Bcl-2 Family Proteins, Journal of Pharmacology and Experimental Therapeutics, vol.318, issue.1, pp.186-94, 2006.
DOI : 10.1124/jpet.105.100537